|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 753 BDT | -2.00% |
|
-2.36% | -7.68% |
Ambee Pharmaceuticals Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was BDT 180.99 million compared to BDT 98.98 million a year ago. Net income was BDT 8.06 million compared to net loss of BDT 13.01 million a year ago.
Basic earnings per share from continuing operations was BDT 3.36 compared to basic loss per share from continuing operations of BDT 5.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.68% | 15.47M | |
| +19.62% | 43.27B | |
| +24.52% | 22.92B | |
| +20.29% | 15.43B | |
| +7.48% | 12.95B | |
| +42.51% | 11.83B | |
| -8.84% | 6.91B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.13% | 5.55B |
AMBEE PHARMACEUTICALS PLC 
